Occult hypoperfusion and mortality in patients with suspected infection
- 1.4k Downloads
To determine, in the early stages of suspected clinically significant infection, the independent relationship of the presenting venous lactate level to 28-day in-hospital mortality.
Prospective, observational cohort study.
Urban, university tertiary-care hospital.
One thousand two hundred and eighty seven adults admitted through the emergency department who had clinically suspected infection and a lactate measurement.
Measurements and results
Seventy-three [5.7% (95% CI 4.4–6.9%)] patients died in the hospital within 28 days. Lactate level was strongly associated with 28-day in-hospital mortality in univariate analysis (p < 0.0001). When stratified by blood pressure, lactate remained associated with mortality (p < 0.0001). Normotensive patients with a lactate level ≥ 4.0 mmol/l had a mortality rate of 15.0% (6.0–24%). Patients with either septic shock or lactate ≥ 4.0 mmol/l had a mortality rate of 28.3% (21.3–35.3%), which was significantly higher than those who had neither [mortality of 2.5% (1.6–3.4%), p < 0.0001]. In a model controlling for age, blood pressure, malignancy, platelet count, and blood urea nitrogen level, lactate remained strongly associated with mortality. Patients with a lactate level of 2.5–4.0 mmol/l had adjusted odds of death of 2.2 (1.1–4.2); those with lactate ≥ 4.0 mmol/l had 7.1 (3.6–13.9) times the odds of death. The model had good discrimination (AUC = 0.87) and was well calibrated.
In patients admitted with clinically suspected infection, the venous lactate level predicts 28-day in-hospital mortality independent of blood pressure and adds significant prognostic information to that provided by other clinical predictors.
KeywordsSepsis Infection Lactic acid/lactate Triage Prognosis Risk assessment
- 4.Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121PubMedCrossRefGoogle Scholar
- 5.Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRefGoogle Scholar
- 13.Myint PK, Kamath AV, Vowler SL, Maisey DN, Harrison BD (2005) The CURB (confusion, urea, respiratory rate and blood pressure) criteria in community-acquired pneumonia (CAP) in hospitalised elderly patients aged 65 years and over: a prospective observational cohort study. Age Ageing 34:75–77PubMedCrossRefGoogle Scholar
- 38.Yegenaga I, Hoste E, Van Biesen W, Vanholder R, Benoit D, Kantarci G, Dhondt A, Colardyn F, Lameire N (2004) Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis 43:817–824PubMedCrossRefGoogle Scholar
- 40.Society BT. BTS Guidelines for the management of community acquired pneumonia in adults – 2004 update. 2004 April 4, 2004 [cited 2006 October 1, 2006]; available from: http://www.brit-thoracic.org.uk/c2/uploads/MACAPrevisedApr04.pdf